Beijing Bohui Innovation Biotechnology Group Co., Ltd. is a leading provider of integrated solutions, testing systems, and standard substances for human trace elements in China. The company specializes in the research and development of rapid testing technology for clinical laboratory diagnostics, as well as the development, production, and sales of application product systems. They have pioneered the application of atomic absorption spectroscopy in the rapid testing of human trace elements in clinical diagnostics. The company operates through a business model of "instruments + dedicated reagents" in the field of clinical diagnostics, with two major technological platforms based on atomic absorption spectroscopy and immunofluorescence chromatography. In June 2015, the company underwent a major asset restructuring and subsequently focused on its main business driven by in vitro diagnostic products and blood products. On July 17, 2018, the company changed its name from "Beijing Bohui Innovation Optoelectronic Technology Co., Ltd." to "Beijing Bohui Innovation Biotechnology Co., Ltd." On August 18, 2021, the company changed its name to "Beijing Bohui Innovation Biotechnology Group Co., Ltd."
Headquarters
9 Life Science Park Road Changping District Beijing
Beijing; Beijing;
Postal Code: 102206
Contact Details: Purchase the Beijing Bohui Innovation Biotechnology Group Co., Ltd. report to view the information.
Website: http://www.bohui-tech.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service